Temporal lobe epilepsy is a serious disease for which there is no preventative and no cure. Moreover, available therapies are often ineffective, and medication side effects can be severe, particularly in children. In an effort to develop better treatments for the disease, we seek to understand how normal brains become epileptic. Elucidating the mechanisms of epileptogenesis will prove critical for treating, and ultimately curing, the disease. Recent advances in neuroscience have revealed that new brain cells are generated in adults. While these new brain cells likely play important roles in healthy humans, we believe that abnormal development and integration of these new cells contributes to the development of epilepsy. To determine whether adult-generated brain cells should be targeted for developing new treatments for epilepsy, we have developed a mouse model system which allows us to compare the structure of existing and newly-generated brain cells during the development of epilepsy. These studies will establish whether the new cells are selectively vulnerable to developing changes likely to promote epilepsy. Initial studies confirm the newborn cells develop hallmark pathologies of the epileptic brain, while mature cells appear unaffected. In a second set of experiments, we will examine the impact of seizures on the integration of new brain cells. Epilepsy frequently develops following neurological injuries such as head trauma, hypoxia or status epilepticus. Abnormal integration of new brain cells may result as a direct consequence of this initial injury. Alternatively, the initial injury may result in the occurrence of spontaneous seizures, and these seizures, in turn, may disrupt new cell integration. To distinguish between these possibilities, seizure frequency will be assessed in mice for several months following an epileptogenic brain insult. The morphology of cells born after the insult will be correlated with the presence and frequency of seizures in these animals. Importantly, the outcome of this study will determine whether seizure control might be an effective target for promoting the correct integration of newborn brain cells. Finally, to determine whether abnormally integrated newborn brain cells can be targeted to cure epilepsy, we will utilize a transgenic mouse model which will allow us to selective ablate newborn cells from the epileptic brain. These studies will be the first to examine the impact of selectively ablating any abnormal cell population from the epileptic brain, and it is our hope that our findings will provide the basis for developing new and more effective treatments for epilepsy.

Public Health Relevance

In adults, new brain cells are born daily in the hippocampus, a region pivotal to the development of common forms of epilepsy. Abnormal incorporation of these new cells into the brain may promote the development of the disease. This proposal will elucidate the contribution of these new neurons to pathology, development and maintenance of epilepsy. By determining how normal brains become epileptic, we can begin to develop therapies to delay, halt and ultimately reverse the process.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Acute Neural Injury and Epilepsy Study Section (ANIE)
Program Officer
Fureman, Brandy E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Santos, Victor R; Pun, Raymund Y K; Arafa, Salwa R et al. (2017) PTEN deletion increases hippocampal granule cell excitability in male and female mice. Neurobiol Dis 108:339-351
Arya, Ravindra; Wilson, J Adam; Fujiwara, Hisako et al. (2017) Presurgical language localization with visual naming associated ECoG high- gamma modulation in pediatric drug-resistant epilepsy. Epilepsia 58:663-673
Hosford, Bethany E; Rowley, Shane; Liska, John P et al. (2017) Ablation of peri-insult generated granule cells after epilepsy onset halts disease progression. Sci Rep 7:18015
Rowley, Shane; Sun, Xiaofei; Lima, Isabel V et al. (2017) Cannabinoid receptor 1/2 double-knockout mice develop epilepsy. Epilepsia 58:e162-e166
LaSarge, Candi L; Pun, Raymund Y K; Muntifering, Michael B et al. (2016) Disrupted hippocampal network physiology following PTEN deletion from newborn dentate granule cells. Neurobiol Dis 96:105-114
Hester, Michael S; Hosford, Bethany E; Santos, Victor R et al. (2016) Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain. Exp Neurol 280:1-12
Hosford, Bethany E; Liska, John P; Danzer, Steve C (2016) Ablation of Newly Generated Hippocampal Granule Cells Has Disease-Modifying Effects in Epilepsy. J Neurosci 36:11013-11023
Wulsin, Aynara C; Solomon, Matia B; Privitera, Michael D et al. (2016) Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy. Physiol Behav 166:22-31
Gross, Christina; Yao, Xiaodi; Engel, Tobias et al. (2016) MicroRNA-Mediated Downregulation of the Potassium Channel Kv4.2 Contributes to Seizure Onset. Cell Rep 17:37-45
Jiang, Yifei; Tong, Dongyi; Hofacer, Rylon D et al. (2016) Long-term Fate Mapping to Assess the Impact of Postnatal Isoflurane Exposure on Hippocampal Progenitor Cell Productivity. Anesthesiology 125:1159-1170

Showing the most recent 10 out of 28 publications